SP-mediated statistically significant reductions in both Sm and COPD-S were observed for SR-AI, CD1d, and TLR4, and additional significant reductions were observed for CD35 in Sm, and TLR2 in COPD-S. This evidence concerns the gene CD1D and chronic obstructive pulmonary disease.